SMALL LYMPHOCYTIC LEUKEMIA
Clinical trials for SMALL LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new SMALL LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for SMALL LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug candidate BR101801 tested in advanced blood cancers
Disease control CompletedThis early-phase trial tested an experimental drug called BR101801 in 26 adults with advanced blood cancers like lymphoma and leukemia that had not responded to prior treatments. The main goals were to find a safe dose and check for side effects. The study is complete, but it is …
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 16:53 UTC
-
Could early ibrutinib stop CLL before it starts?
Disease control CompletedThis study tested whether giving the drug ibrutinib early to people with chronic lymphocytic leukemia (CLL) who have no symptoms but are at high risk for progression could be more effective than waiting. Twenty-three participants took ibrutinib daily for up to 24 months. The goal…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 13:06 UTC
-
CLL patients left in the dark: study maps treatment gaps after key drug fails
Knowledge-focused CompletedThis study looked at 152 adults with chronic lymphocytic leukemia (CLL) whose cancer stopped responding to a class of drugs called BTK inhibitors (like ibrutinib) and, in some cases, also to venetoclax. The goal was to understand what treatments doctors used next and how well the…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC